← feed

Is NCT03298906 results overdue?

Yes — results are overdue. Primary completion was 2017-11-27; the FDAAA-801 reporting deadline (2018-11-27) passed 2763 days ago and no results are posted on ClinicalTrials.gov.

A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants

NCT IDNCT03298906 ↗
SponsorJanssen Research & Development, LLC (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-11-27 (ACTUAL)
Reporting deadline2018-11-27 (completion + 365d)
Days overdue2763
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 3d088050058eee23… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03298906. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →